Market Value4,840,715,217
Total Holdings76
File Date2025-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
US40637HAF64 / CONV. NOTE
US737446AT14 / CONV. NOTE
HSIC / Henry Schein, Inc.
US26210CAD65 / Dropbox, Inc.
CRGY / Crescent Energy Company
DEC / Diversified Energy Company PLC
BV / BrightView Holdings, Inc.
US516544AB96 / CONV. NOTE
US91332UAB70 / CONVERTIBLE ZERO
FSK / FS KKR Capital Corp.
US57164YAD94 / MARRIOTT VACATIONS WRLDWD CORP CONV 0% 01/15/2026
US02376RAF91 / American Airlines Group Inc
SHOP / Shopify Inc.
US538034BA63 / CONV. NOTE
US12685JAE55 / Cable One Inc
US703343AG80 / Patrick Industries Inc
US09061GAK76 / CONV. NOTE
NVCR / NovoCure Limited
US83304AAH95 / SNAP INC
MSGS / Madison Square Garden Sports Corp.
US12685JAG04 / CONV. NOTE
BTSG / BrightSpring Health Services, Inc.
US62886HBD26 / NCL Corp Ltd
BBIO / BridgeBio Pharma, Inc.
US531229AQ58 / CONV. NOTE
FOUR.PRA / Shift4 Payments, Inc. - Preferred Stock
BLACKLINE INC / NOTE 1.000% 6/0 (09239BAF6)
MKS INC. / NOTE 1.250% 6/0 (55306NAB0)
MERITAGE HOMES CORP / NOTE 1.750% 5/1 (59001ABF8)
MIRUM PHARMACEUTICALS INC / NOTE 4.000% 5/0 (604749AB7)
ENOVIS CORPORATION / NOTE 3.875%10/1 (194014AB2)
ON SEMICONDUCTOR CORP / NOTE 0.500% 3/0 (682189AU9)
PPL CAP FDG INC / NOTE 2.875% 3/1 (69352PAS2)
PAGERDUTY INC / NOTE 1.500%10/1 (69553PAD2)
PARSONS CORP DEL / NOTE 2.625% 3/0 (70202LAD4)
PROGRESS SOFTWARE CORP / NOTE 3.500% 3/0 (743312AD2)
DEXCOM INC / NOTE 0.375% 5/1 (252131AM9)
ENVISTA HOLDINGS CORPORATION / NOTE 1.750% 8/1 (29415FAD6)
FLUOR CORP / NOTE 1.125% 8/1 (343412AJ1)
SABRE GLBL INC / NOTE 7.320% 8/0 (78573NAK8)
SEAGATE HDD CAYMAN / NOTE 3.500% 6/0 (81180WBL4)
SNAP INC / NOTE 0.500% 5/0 (83304AAK2)
US87918AAF21 / CONV. NOTE
SPECTRUM BRANDS INC / NOTE 3.375% 6/0 (84762LAZ8)
TANDEM DIABETES CARE INC / NOTE 1.500% 3/1 (875372AD6)
AKAMAI TECHNOLOGIES INC / NOTE 1.125% 2/1 (00971TAN1)
ALARM COM HLDGS INC / NOTE 2.250% 6/0 (011642AD7)
AMERICAN WTR CAP CORP / NOTE 3.625% 6/1 (03040WBE4)
GLOBAL PMTS INC / NOTE 1.500% 3/0 (37940XAU6)
IMMUNOCORE HLDGS PLC / NOTE 2.500% 2/0 (45258DAB1)
INTEGER HLDGS CORP / NOTE 2.125% 2/1 (45826HAB5)
IONIS PHARMACEUTICALS INC / NOTE 1.750% 6/1 (462222AF7)
ITRON INC / NOTE 1.375% 7/1 (465741AQ9)
UGI CORP NEW / NOTE 5.000% 6/0 (902681AB1)
VENTAS RLTY LTD PARTNERSHIP / NOTE 3.750% 6/0 (92277GAZ0)
WESTERN DIGITAL CORP / NOTE 3.000%11/1 (958102AT2)
WINNEBAGO INDS INC / NOTE 3.250% 1/1 (974637AF7)
WORKIVA INC / NOTE 1.250% 8/1 (98139AAD7)
WORLD KINECT CORPORATION / NOTE 3.250% 7/0 (98149GAB6)
US91879QAN97 / CONVERTIBLE ZERO
BHC / Bausch Health Companies Inc.
KREF / KKR Real Estate Finance Trust Inc.
QXO.PRB / QXO, Inc. - Preferred Security
US477839AB04 / CONV. NOTE
JAZZ / Jazz Pharmaceuticals plc
INSM / Insmed Incorporated
US477143AP66 / CONV. NOTE
US84921RAB69 / Spotify USA Inc
US40131MAB54 / CONVERTIBLE ZERO
NCLH / Norwegian Cruise Line Holdings Ltd.
US40637HAD17 / CONV. NOTE
US75737FAE88 / Redfin Corp
US08265TAD19 / CONV. NOTE
LQD / iShares Trust - iShares iBoxx $ Investment Grade Corporate Bond ETF
CHRS / Coherus Oncology, Inc.
US89422GAA58 / Travere Therapeutics, Inc.
US011642AB16 / CONVERTIBLE ZERO